Recursion Pharmaceuticals IPO Info

Company Name: Recursion Pharmaceuticals
Stock Symbol: RXRX
Exchange: NASDAQ
Status: Priced
IPO Date: 4/16/2021
IPO Price: 18.00 (17.67%)
Underwriters
Goldman Sachs & Co. LLC and J.P. Morgan

Amount of Offering: N/A
Number of Shares Offered: 24.242 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.

News Headlines